2.85

10.09% -0.32

After Hours: 2.93 0.08 +2.81%

Beyond Air Inc (XAIR)

Overview News Price History Option Chain Financials Why XAIR Down? Discussions Forecast Stock Split

Beyond Air Inc stock is traded at $2.85, with a volume of 194.31K. It is down -10.09% in the last 24 hours and down -42.77% over the past month. Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.

Previous Close:

$3.17

Open:

24h Volume:

194.31K

Relative Volume:

0.94

Market Cap:

$2.81M

Revenue:

$7.68M

Net Income/Loss:

$-34.33M

P/E Ratio:

-0.0323

EPS:

-88.1566

Net Cash Flow:

$-19.17M

1W Performance:

-7.77%

1M Performance:

-42.77%

6M Performance:

-80.74%

1Y Performance:

-93.88%

1-Day Range:

$2.775

$3.00

1-Week Range:

$2.775

$3.2191

52-Week Range:

$2.775

$55.60

Beyond Air Inc Stock (XAIR) Company Profile

Name

Beyond Air Inc

Sector

Healthcare (1067)

Industry

Medical Devices (139)

Phone

516-665-8200

Address

900 STEWART AVENUE, GARDEN CITY, NY

Employee

Twitter

@BeyondAirInc

Next Earnings Date

2026-11-09

Latest SEC Filings

XAIR's Discussions on Twitter

Compare XAIR vs ABT, MDT, SYK, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XAIR Beyond Air Inc	2.85	2.81M	7.68M	-34.33M	-19.17M	-88.16
ABT Abbott Laboratories	101.29	175.27B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	88.64	113.38B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	272.36	104.47B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.92	63.65B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	86.29	49.74B	6.30B	1.07B	1.09B	1.8406

Beyond Air Inc Stock (XAIR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-17-25	Initiated	D. Boral Capital	Buy
Jun-25-24	Downgrade	BTIG Research	Buy → Neutral
Jul-28-23	Initiated	Piper Sandler	Overweight
Jun-15-23	Initiated	BTIG Research	Buy
Apr-28-21	Initiated	Truist	Buy
Oct-22-19	Initiated	Oppenheimer	Outperform

View All

Beyond Air Inc Stock (XAIR) Latest News

Sep 24, 2026

Beyond Air Slips After Disclosure of Long-Term Employment Contract for CEO - Moomoo

Sep 24, 2026

Beyond Air Formalizes CEO Agreement, Boosts CFO Compensation - TipRanks

Sep 24, 2026

Lucid, Beyond Air, Conagra Stocks Hit 52-Week Lows: What's Behind The Drag? - Stocktwits

Sep 24, 2026

Sep 19, 2026

Beyond Air, Inc. Revenue Breakdown – GETTEX:48L - TradingView

Sep 19, 2026

Sep 17, 2026

Beyond Air, Long Island company, covered up defects in device treating cancer patients, lawsuit says - Newsday

Sep 17, 2026

Sep 10, 2026

XAIR: Generation 2 device approval is set to unlock a $400M+ market with immediate deployment planned - TradingView

Sep 10, 2026

Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com Canada

Sep 10, 2026

XAIR: Generation 2 enables immediate entry into the $400M U.S. transport market upon FDA approval - TradingView

Sep 10, 2026

Beyond Air at cantors conference: generation 2 is the focus - Investing.com India

Sep 10, 2026

Sep 04, 2026

Beyond Air Inc (NASDAQ: XAIR) Share Price, XAIR Stock News, XAIR Share Price & Updates - Kalkine

Sep 04, 2026

Sep 02, 2026

At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan

Sep 02, 2026

Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference - Yahoo Finance

Sep 02, 2026

Sep 01, 2026

XAIR Initiates Coverage On Beyond Air -- Rating Set to Buy - GuruFocus

Sep 01, 2026

Lake Street Initiates Beyond Air at Buy With $10 Price Target - marketscreener.com

Sep 01, 2026

Lake Street Initiates Beyond Air(XAIR.US) With Buy Rating, Announces Target Price $10 - Moomoo

Sep 01, 2026

Aug 31, 2026

XAIR Looks 98.9% Undervalued on GF Value™ Despite Financial Stru - GuruFocus

Aug 31, 2026

Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - The Manila Times

Aug 31, 2026

Beyond Air Announces FDA Breakthrough Device Designation for LungFit GO in NTM-PD Treatment - Quiver Quantitative

Aug 31, 2026

A portable treatment for hard-to-treat lung infections gets FDA breakthrough status - Stock Titan

Aug 31, 2026

Aug 25, 2026

Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal - citybiz

Aug 25, 2026

Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com Nigeria

Aug 25, 2026

Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity - Investing.com India

Aug 25, 2026

Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - marketscreener.com

Aug 25, 2026

Aug 20, 2026

Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus

Aug 20, 2026

Aug 19, 2026